Most of the current research on Cav-1 in breast cancer has demonstrated that loss of Cav-1 expression in the stromal cells surrounding the tumor is associated with early tumor recurrence and poor clinical outcome [5,6]. The gene discussed is CAV1; the disease is neoplasm.